Immunophenotyping in pemphigus reveals a TH17/TFH17 cell-dominated immune response promoting desmoglein1/3-specific autoantibody production
- PMID: 33221382
- DOI: 10.1016/j.jaci.2020.11.008
Immunophenotyping in pemphigus reveals a TH17/TFH17 cell-dominated immune response promoting desmoglein1/3-specific autoantibody production
Abstract
Background: TH2 cells were thought to be a pivotal factor for initiation of the autoimmune blistering disease pemphigus. However, the role of other T-cell subsets in pemphigus pathogenesis remained unclear.
Objective: We aimed to characterize the exact phenotype of T cells responsible for the development of pemphigus.
Methods: Whole transcriptome shotgun sequencing was performed to determine differential gene expression in pemphigus lesions and skin of healthy individuals. The cutaneous cytokine signature was further evaluated by real-time quantitative PCR. In peripheral blood, the distribution of TH cell and folliclular helper (TFH) cell subsets was analyzed by flow cytometry. Finally, the capacity of TH and TFH cell subsets to induce desmoglein (Dsg)-specific autoantibodies by memory B cells was evaluated in coculture experiments.
Results: Transcriptome analysis of skin samples identified an IL-17A-dominated immune signature in patients with pemphigus, and Kyoto Encyclopedia of Genes and Genomes pathway analysis confirmed the dominance of the IL-17A signaling pathway. Increased expression of IL17A and associated cytokines was also detected by real-time quantitative PCR comparing lesional with perilesional or healthy skin. Interestingly, utilization of flow cytometry showed that patients with active pemphigus had elevated levels of circulating IL-17+, TH17, TFH17, and TFH17.1 cells. Notably, levels of TH17 and TFH17 cells correlated with levels of Dsg-specific CD19+CD27+ memory B cells, and patients with acute pemphigus showed higher levels of Dsg3-autoreactive TFH17 cells. Coculture experiments revealed TFH17 cells as primarily responsible for inducing Dsg-specific autoantibody production by B cells.
Conclusion: Our findings show that TFH17 cells are critically involved in the pathogenesis of pemphigus and offer novel targets for therapeutic intervention.
Keywords: IL-17; Pemphigus vulgaris; T-cell–B-cell interaction; autoantibodies; autoimmunity; bullous disease; desmoglein; follicular T cells; helper T cells; pemphigus foliaceus.
Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris.Front Immunol. 2019 Jun 14;10:1375. doi: 10.3389/fimmu.2019.01375. eCollection 2019. Front Immunol. 2019. PMID: 31258541 Free PMC article.
-
The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris.Br J Dermatol. 2024 Sep 18;191(4):605-615. doi: 10.1093/bjd/ljae220. Br J Dermatol. 2024. PMID: 38848544
-
Altered circulating T follicular helper cell subsets in patients with psoriasis vulgaris.Immunol Lett. 2017 Jan;181:101-108. doi: 10.1016/j.imlet.2016.09.008. Epub 2016 Sep 20. Immunol Lett. 2017. PMID: 27662792
-
Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.J Autoimmun. 2008 Dec;31(4):311-24. doi: 10.1016/j.jaut.2008.08.003. Epub 2008 Oct 5. J Autoimmun. 2008. PMID: 18838249 Free PMC article. Review.
-
Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.Clin Rev Allergy Immunol. 2018 Feb;54(1):1-25. doi: 10.1007/s12016-017-8662-z. Clin Rev Allergy Immunol. 2018. PMID: 29313220 Review.
Cited by
-
A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus.Vaccines (Basel). 2024 Jul 30;12(8):857. doi: 10.3390/vaccines12080857. Vaccines (Basel). 2024. PMID: 39203983 Free PMC article. Review.
-
Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.Clin Rev Allergy Immunol. 2021 Dec;61(3):351-362. doi: 10.1007/s12016-021-08882-1. Epub 2021 Aug 4. Clin Rev Allergy Immunol. 2021. PMID: 34350539 Review.
-
Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2.J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e649-e651. doi: 10.1111/jdv.17480. Epub 2021 Jul 12. J Eur Acad Dermatol Venereol. 2021. PMID: 34169588 Free PMC article. No abstract available.
-
Detection of rare autoreactive T cell subsets in patients with pemphigus vulgaris.Front Immunol. 2022 Sep 20;13:979277. doi: 10.3389/fimmu.2022.979277. eCollection 2022. Front Immunol. 2022. PMID: 36203615 Free PMC article.
-
Autoimmune Pemphigus: Latest Advances and Emerging Therapies.Front Mol Biosci. 2022 Feb 4;8:808536. doi: 10.3389/fmolb.2021.808536. eCollection 2021. Front Mol Biosci. 2022. PMID: 35187073 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous